Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT199200060ApriorityCriticalpatent/GT199200060A/en
Publication of GT199200060ApublicationCriticalpatent/GT199200060A/en
SE REFIERE A NUEVOS DERIVADOS DE NACILALFAAMINO ACIDO, UNPROCEDIMIENTO PARA SU PREPARACION, PREPARADOS FARMACEUTICOS QUE CONTIENEN ESTOS COMPUESTOS, ASI COMO EL EMPLEO DE ESTOS EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS. SE REFIEREEN PARTICULAR, A DERIVADOS DE ACIDO NAROILALFA0AMINOCARBIXILICO DE ESTRUCTURA QUIMICA I CONTENIDA EN LA FICHA TECNICARESPECTIVA. ESTOS COMPUESTOS PUEDEN UTILIZARSE PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES QUE ESTAN CAUSADAS POR LA LIGAZON DE PROTEINAS ADHESIVAS A PLAQUETAS SANGUINEAS Y POR LO AGREGACION DE PLAQUETAS SANGUINEAS Y ADHESION..../..IT REFERS TO NEW DERIVATIVES OF NACILALFAAMINO ACID, A PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THE USE OF THESE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. THEY SPECIFICALLY REFER TO DERIVATIVES OF NAROILALFA0AMINOCARBIXILIC ACID OF CHEMICAL STRUCTURE I CONTAINED IN THE TECHNICAL DATA SHEET. THESE COMPOUNDS MAY BE USED FOR THE TREATMENT OR PROPHYLAXIS OF DISEASES THAT ARE CAUSED BY THE LINKAGE OF BLOOD PROTEINS ADHESIVE AND BY THE ADDITION OF BLOOD PLATES AND ADHESION .... / ..
GT199200060A1992-09-291992-09-29
DERIVATIVES OF N-ACIL-ALPHA AMINO ACID
GT199200060A
(en)
Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound.
Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound
Compound, process for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, and use of a compound and process to prepare it.
Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and, processes for effecting immunosuppression and for treating or reducing the risk of reversibly obstructive airway disease in a patient
compound, use thereof, pharmaceutical composition, aerosol pharmaceutical formulation, method for treating a human or animal patient with an anti-inflammatory and / or allergic condition, and process for preparing a compound.
PHARMACEUTICAL COMPOSITION CONTAINING A MIXTURE OF COLLAGEN AND AN ANTISEPTIC AND/OR ANTI-INFLAMMATORY ACTIVE INGREDIENT AND PROCESS FOR PRODUCTION THEREOF.
Compound, pharmaceutical composition, use of a compound, processes to treat or prevent diseases of the endocrinological system, to manufacture a drug, to prepare a compound and a set, and use of it.